VRNA
Verona Pharma
VRNA
VRNA
Delisted
VRNA was delisted on the 6th of October, 2025.
14 hedge funds and large institutions have $33.7M invested in Verona Pharma in 2019 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 3 increasing their positions, 0 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
14
Holders Change
+1
Holders Change %
+7.69%
% of All Funds
0.28%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
2
Increased
3
Reduced
–
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
Top Sellers
| 1 |
PC
Polar Capital
London,
United Kingdom
|
-$457K |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
O
1
OrbiMed
New York
| $7.19M | – | – | – |
|
|
NMC
2
NEA Management Company
Timonium,
Maryland
| $7.01M | – | – | – |
|
|
A
3
Abingworth
London,
United Kingdom
| $5.23M | – | – | – |
|
|
VP
4
venBio Partners
San Francisco,
California
| $5.03M | – | – | – |
|
|
NHAS
5
Novo Holdings A/S
Hellerup,
Denmark
| $4.26M | – | – | – |
|
|
ACM
6
Aisling Capital Management
New York
| $2.55M | – | – | – |
|
|
TCM
7
Tekla Capital Management
Boston,
Massachusetts
| $1.58M | – | – | – |
|
|
WS
8
Wedbush Securities
Los Angeles,
California
| $466K | +$292K | +50,785 | +168% |
|
|
IWM
9
IHT Wealth Management
Chicago,
Illinois
| $118K | – | – | – |
|
10
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| $88K | +$88K | +15,375 | New |
|
11
Renaissance Technologies
New York
| $72K | +$72K | +12,500 | New |
|
12
UBS Group
Zurich,
Switzerland
| $58K | +$51.6K | +8,940 | +802% |
|
13
US Bancorp
Minneapolis,
Minnesota
| $22K | – | – | – |
|
14
Deutsche Bank
Frankfurt Am Main Ge,
Germany
| $2K | +$308 | +68 | +18% |
|
|
PC
15
Polar Capital
London,
United Kingdom
| – | -$457K | -100,000 | Closed |
|